ROXI-APEX - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL,
SPONSOR-BLINDED, STUDY TO EVALUATE REGN7508, A FACTOR XI
MONOCLONAL ANTIBODY, VERSUS APIXABAN AND ENOXAPARIN
FOR PROPHYLAXIS OF VENOUS THROMBOEMBOLISM AFTER
ELECTIVE TOTAL KNEE ARTHROPLASTY (ROXI-APEX)
Principal Investigator
Thorsten M. Seyler, MD, PhD
Joint Replacement Surgeon
Protocol Number
IRB:
PRO00119175
NCT:
NCT07015905
Phase
Phase III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment